TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Investigation finds no evidence FDA’s Crawford had affair with subordinate. June 10, 2005
TCL Archive Bill To Teach Breast Self-Exam To Teens Wins Political Support; Experts Fear Harm April 10, 2009
TCL Archive NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use December 7, 1984
